Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-005582

Matsuda Masaru sold 40,638 shares at an average $25.28 ($1,027,293)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Matsuda Masaru

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −7,983 $25.50 $203,554 142,658 D
2026-02-02 Sale : show line 2 in the form 10b5-1 −8,562 $24.97 $213,793 134,096 D
2026-02-02 Sale : show line 3 in the form 10b5-1 −19,379 $25.24 $489,126 114,717 D
2026-02-02 Sale : show line 4 in the form 10b5-1 −4,714 $25.63 $120,820 110,003 D
Open-market sales · 40,638 sh · avg $25.28 · $1,027,293
Loading xslF345X05/wk-form4_1770255345.xml…